Nectar Lifesciences Ltd Q1 FY2023 consolidated profit at Rs. 3.89 crores

Nectar Lifesciences Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 403.3873 crores during the period ended June 30, 2022 as compared to Rs. 476.7533 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 3.8994 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 11.66 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.17 for the period ended June 30, 2022 as compared to Rs. 0.52 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 403.3873 crs	₹476.7533 crs	-15.39%
Net Profit	₹3.8994 crs	₹11.66 crs	-66.56%
EPS	₹0.17	₹0.52	-67.31%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 403.3873 crores during the period ended June 30, 2022 as compared to Rs.390.1990 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.3.8994 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.1.7940 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.17 for the period ended June 30, 2022 as compared to Rs.0.08 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 403.3873 crs	₹390.1990 crs	3.38%
Net Profit	₹3.8994 crs	₹1.7940 crs	117.36%
EPS	₹0.17	₹0.08	112.50%

Shares of Nectar Lifesciences Limited was last trading in BSE at Rs. 24.50 as compared to the previous close of Rs. 24.25. The total number of shares traded during the day was 24327 in over 316 trades.

The stock hit an intraday high of Rs. 24.80 and intraday low of 24.15. The net turnover during the day was Rs. 597311.00.

Source : Equity Bulls

Keywords

NectarLifesciences Q1FY23 ResultUpdate